Pfizer's stock falls after profit misses expectations, while revenue was in line

Shares of Pfizer Inc. PFE, -0.48% fell 0.9% in premarket trading Tuesday, after the drug maker reported a fourth-quarter profit that missed expectations, while revenue rose in line with forecasts. The company reported a net loss that narrowed to $337 million, or 6 cents a share, from $394 million, or 7 cents a share, in the year-ago period. Excluding non-recurring items, adjusted earnings per share fell to 55 cents from 63 cents, below the FactSet consensus of 58 cents. Sales fell 9% to $12.69 billion to match the FactSet consensus, as biopharma sales rose 7% to $10.53 billion and Upjohn sales dropped 32% to $2.16 billion. For 2020, Pfizer expects adjusted EPS to be $2.82 to $2.92, surrounding the FactSet consensus of $2.90, and revenue of $48.5 billion to $50.5 billion, compared with expectations of $49.6 billion. The stock has rallied 7.7% over the past three months through Monday, while the Dow Jones Industrial Average DJIA, +0.52% has gained 5.3%.